Rep. Lloyd Doggett Purchases Shares of Johnson & Johnson (NYSE:JNJ)

Representative Lloyd Doggett (D-Texas) recently bought shares of Johnson & Johnson (NYSE:JNJ). In a filing disclosed on July 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in Johnson & Johnson stock on June 10th.

Representative Lloyd Doggett also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 6/18/2025.
• Purchased $1,001 – $15,000 in shares of PPG Industries (NYSE:PPG) on 6/12/2025.
• Purchased $1,001 – $15,000 in shares of International Business Machines (NYSE:IBM) on 6/10/2025.
• Purchased $1,001 – $15,000 in shares of Procter & Gamble (NYSE:PG) on 5/15/2025.

Johnson & Johnson Stock Up 0.4%

JNJ opened at $163.65 on Friday. The stock has a market capitalization of $393.75 billion, a price-to-earnings ratio of 17.50, a P/E/G ratio of 2.19 and a beta of 0.41. Johnson & Johnson has a 1-year low of $140.68 and a 1-year high of $169.99. The business has a 50 day moving average of $154.29 and a 200-day moving average of $155.05. The company has a current ratio of 1.26, a quick ratio of 1.03 and a debt-to-equity ratio of 0.49.

Johnson & Johnson (NYSE:JNJ) last announced its earnings results on Wednesday, July 16th. The company reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.68 by $0.09. The company had revenue of $23.74 billion during the quarter, compared to analyst estimates of $22.85 billion. Johnson & Johnson had a return on equity of 33.07% and a net margin of 25.00%. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company posted $2.82 earnings per share. As a group, sell-side analysts anticipate that Johnson & Johnson will post 10.58 earnings per share for the current year.

Johnson & Johnson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 26th will be given a dividend of $1.30 per share. The ex-dividend date is Tuesday, August 26th. This represents a $5.20 dividend on an annualized basis and a yield of 3.18%. Johnson & Johnson’s payout ratio is currently 55.61%.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Barclays boosted their target price on Johnson & Johnson from $165.00 to $176.00 and gave the company an “equal weight” rating in a research note on Thursday. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Johnson & Johnson in a report on Wednesday, April 16th. Leerink Partners lowered Johnson & Johnson from an “outperform” rating to a “market perform” rating and reduced their target price for the stock from $169.00 to $153.00 in a report on Tuesday, May 13th. Bank of America increased their target price on Johnson & Johnson from $161.00 to $175.00 and gave the company a “neutral” rating in a research report on Thursday. Finally, Guggenheim lifted their price objective on Johnson & Johnson from $164.00 to $167.00 and gave the stock a “neutral” rating in a research note on Thursday. Eleven investment analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, Johnson & Johnson currently has a consensus rating of “Moderate Buy” and an average target price of $172.87.

Hedge Funds Weigh In On Johnson & Johnson

A number of hedge funds and other institutional investors have recently modified their holdings of JNJ. Brighton Jones LLC boosted its holdings in Johnson & Johnson by 13.9% during the 4th quarter. Brighton Jones LLC now owns 51,876 shares of the company’s stock valued at $7,502,000 after acquiring an additional 6,332 shares during the period. Hudson Value Partners LLC raised its position in Johnson & Johnson by 2.5% during the 4th quarter. Hudson Value Partners LLC now owns 41,403 shares of the company’s stock valued at $5,648,000 after purchasing an additional 1,022 shares during the last quarter. Proficio Capital Partners LLC raised its position in Johnson & Johnson by 22.0% during the 4th quarter. Proficio Capital Partners LLC now owns 19,951 shares of the company’s stock valued at $2,885,000 after purchasing an additional 3,594 shares during the last quarter. Raymond James Financial Inc. bought a new position in Johnson & Johnson during the 4th quarter valued at approximately $1,339,878,000. Finally, Banco Santander S.A. raised its position in Johnson & Johnson by 31.0% during the 4th quarter. Banco Santander S.A. now owns 40,803 shares of the company’s stock valued at $5,901,000 after purchasing an additional 9,664 shares during the last quarter. 69.55% of the stock is currently owned by hedge funds and other institutional investors.

About Representative Doggett

Lloyd Doggett (Democratic Party) is a member of the U.S. House, representing Texas’ 37th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Doggett (Democratic Party) is running for re-election to the U.S. House to represent Texas’ 37th Congressional District. He declared candidacy for the 2026 election.

Lloyd Doggett was born in Austin, Texas. Doggett graduated from Austin High School in 1964. He earned a B.A. from the University of Texas at Austin in 1967 and a J.D. from the University of Texas in 1970. Doggett’s career experience includes working as an adjunct professor with the University of Texas School of Law. In the 116th Congress, Doggett served on the House Ways & Means Committee, and he co-founded the House Prescription Drug Taskforce.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.